|
Volumn 109, Issue 2, 1999, Pages 289-294
|
Clinical evolution of laryngeal granulomas: Treatment and prognosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BOTULINUM TOXIN A;
ABUSE;
ADULT;
AGED;
ARTICLE;
CONTROLLED STUDY;
ENDOTRACHEAL INTUBATION;
FEMALE;
GASTROESOPHAGEAL REFLUX;
HUMAN;
IDIOPATHIC DISEASE;
LARYNX GRANULOMA;
LARYNX SURGERY;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
SPEECH THERAPY;
VOICE;
ADOLESCENT;
ADULT;
AGED;
ANTI-ULCER AGENTS;
ANTIEMETICS;
BOTULINUM TOXIN TYPE A;
COMBINED MODALITY THERAPY;
DISEASE PROGRESSION;
DOMPERIDONE;
FEMALE;
GASTROESOPHAGEAL REFLUX;
GRANULOMA;
HUMANS;
LARYNGEAL DISEASES;
MALE;
MIDDLE AGED;
NEUROMUSCULAR AGENTS;
OMEPRAZOLE;
PROGNOSIS;
RECURRENCE;
RETROSPECTIVE STUDIES;
SPEECH DISORDERS;
SPEECH THERAPY;
TREATMENT OUTCOME;
VERBAL BEHAVIOR;
|
EID: 0033021881
PISSN: 0023852X
EISSN: 15314995
Source Type: Journal
DOI: 10.1097/00005537-199902000-00021 Document Type: Article |
Times cited : (58)
|
References (11)
|